JUN 05, 2018 09:45 PM PDT

Precision vs. Personalized Medicine Part I: Precision Approach

Are you hearing a lot about personalized medicine these days?  What about precision medicine? It seems like the information being discussed is not necessarily new.  Why does it seem to be everywhere lately?  There are many answers to that but this two part series aims to outline some of the features of these models of medicine as a foundation.

Precision medicine is defined as a model for medicine that is customized based on the individual patient; all aspects of care can be personalized including medical decisions, treatments, practices, and products or services used.  Another similar sounding term is “personalized medicine”.  That National Institutes of Health indicates that there is overlap in the two terms.  The real difference is mostly in the interpretation of the word “personalized” as compared to “precision”. 

Precision, as a single word, means to hit a target in the same place over and over.  Precision medicine aims to create medicine models that target a similar feature of a disease that appears in multiple diseases or cancers in some cases.  This model is not unique for one single individual, however.  This approach aims to identify which approaches will be effective for patients based on genetic, environmental, and lifestyle aspects. 

The changes in technology and knowledge acquisition over the past few decades allow clinicians and researchers access to heaps of data on different cancer types.  The historical approach has been to lump the cancer types together and treat everyone with that cancer type in the same therapeutic manner.  Yet there are patients that do not respond to that therapy at all despite having the pathology/morphology of one type of cancer.  We now know that there are molecular factors at play, right down to our DNA, which affect how a treatment may work on those cancerous cells.  If the treatment action is based on one pathway leading to disease, what happens when that disease occurs due to a different pathway malfunction?  Precision medicine dumps into the field of computational oncology which employs the expertise of statisticians, mathematicians, physicists, computer scientists, cancer biologists, physiological experts, physicians, researchers, and many more to create data programs and models including genetic profiles and therapeutic approaches for different cancers.  In addition, pharmacogenetics is part of precision medicine because the whole basis of this field of study is how gene’s affect a particular patient’s response to a given pharmaceutical agent.  If you enjoy pharmacology and genomics, this is the field for you.

The National Research Council has documented that they prefer the term precision medicine; the work involves building a network for biomedical research in order to basically develop a new taxonomical structure for disease.  The National Academy of Sciences, in collaboration with the National Academy of Engineering, the Institute of Medicine, and the National Research Council, published a report exploring the future of precision medicine in 2011. 

Sources: NIH – U.S. National Library of Medicine, National Academies Press – National Research Council,  Journal for Biomedical Informatics, Annals of Gastroenterology & Surgery,

 

 

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUN 01, 2018
Health & Medicine
JUN 01, 2018
Research Shows The Cause of Childhood Leukemia
Babies and young children need to be kept safe by the adults in their lives, however keeping them in a germ-free environment might not be the best idea. Ch...
JUN 05, 2018
Cancer
JUN 05, 2018
Clinical Trial Evaluates Precision Medicine Approaches for Common and Rare Cancers
The NCI-MATCH Phase II Clinical Trial is evaluating results of cancer treatments administered based on genetic profiles determined through molecular diagnostic testing....
JUL 26, 2018
Genetics & Genomics
JUL 26, 2018
When a Cancer Gene Switches Sides
All cells carry a gene named p53, which has a vital role in shielding the body from cancer. But it can betray cells too....
SEP 13, 2018
Cancer
SEP 13, 2018
Breast tumors can stop their own metastasis
According to the American cancer society, metastatic breast cancers or stage 4 breast cancers have 5-years survival rate of 22% which is lower than at early stages. Metastatic breast cancer...
SEP 15, 2018
Clinical & Molecular DX
SEP 15, 2018
Cancer & Anoikis: A Match Not Made in Heaven
Anoikis have always been intimately entwined with cancer, henceforth the quest to seek how they came to be as such....
SEP 20, 2018
Genetics & Genomics
SEP 20, 2018
Liquid Phase Separation may Play a Role in Cancer
Not all liquids mix, like oil and water; the phenomenon is called liquid-liquid phase separation. We're learning more about its role in cells....
Loading Comments...